| Literature DB >> 35509720 |
M V Radisic1, J C Walther2, G Werber3, N Pujato1, S Beltramino3, P M Bravo1, A Bello2, M Hunter4.
Abstract
When it is safe to proceed with transplantation after coronavirus disease 2019 (COVID-19) infection is still unknown. We describe the clinical course and management of immunosuppression in a patient with positive real-time polymerase chain reaction (RT-PCR) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a nasopharyngeal swab at the time of kidney transplantation, and with positive antibodies for SARS-CoV-2. The patient had no complications and was discharged with a functioning graft.Entities:
Keywords: Immunosuppression therapy; SARS-CoV-2; kidney transplantation
Year: 2021 PMID: 35509720 PMCID: PMC9013498
Source DB: PubMed Journal: Int J Organ Transplant Med ISSN: 2008-6482